News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Read more10 Common Workplace Injuries Related Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories News Hong Kong Watch & Clock Fair, Salon de TIME conclude successfully News Annual fashion spotlight CENTRESTAGE draws more than 8,500 buyers News Marcus & Millichap’s IPA Capital Markets Announces Strategic Hire of Industry Veteran in Dallas Business Intelligence News Pharmaceutical Technology 2024 Excellence Awards Honor Botanical Solution Inc. (BSI) as Dual Category Award Winner News PennyMac Financial Services, Inc. Announces Changes to Its Board of Directors News VSG Now Listed on Uniswap: Expanding Access and Freedom for Crypto Traders
